RAVIKUMAR BHALAVAT: Open Payments
NPI 1447406624 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 29 payments from 7 companies in 2025. Trend: 2023 $152 · 2024 $264 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $225 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: VRAYLAR, REXULTI, COBENFY, INGREZZA, UZEDY, ONZETRA XSAIL.
Industry payments across MD — which companies pay providers there.
